Canada markets closed

Emerald Health Therapeutics, Inc. (EMHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0360+0.0070 (+24.14%)
At close: 03:50PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0290
Open0.0290
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0290 - 0.0360
52 Week Range0.0200 - 0.1840
Volume70,672
Avg. Volume177,883
Market Cap7.685M
Beta (5Y Monthly)0.84
PE Ratio (TTM)N/A
EPS (TTM)-0.1240
Earnings DateNov 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Emerald Health Therapeutics Provides Bi-Weekly MCTO Status Update

    Vancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").On April 28, 2022, the Company announced that it had applied for a management cease trade order (an "MCTO") with the British Columbia Securities Commission on the ...

  • Newsfile

    Emerald Health Therapeutics, Inc. Provides Second Bi-Weekly MCTO Status Update

    Vancouver, British Columbia--(Newsfile Corp. - June 3, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the "Company") is providing a status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").On April 28, 2022, the Company announced that it had applied for a management cease trade order (a "MCTO") with the British Columbia Securities Commission on the basis that the Comp

  • Newsfile

    Emerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Update

    Vancouver, British Columbia--(Newsfile Corp. - May 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").On April 28, 2022, the Company announced that it had applied for a management cease trade order (a "MCTO") with the British Columbia Securities Commission on the basis that